Factor XIII Deficiency: An Update

Verena Schroeder; Hans P. Kohler

doi:10.1055/s-0033-1353392

Seminars in Thrombosis and Hemostasis, Inhaltsverzeichnis

Semin Thromb Hemost 2013; 39(06): 632-641
DOI: 10.1055/s-0033-1353392

Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Factor XIII Deficiency: An Update

Verena Schroeder

¹University Clinic of Hematology, Hemostasis Research Laboratory, University Hospital, University of Bern, Bern, Switzerland

,

Hans P. Kohler

¹University Clinic of Hematology, Hemostasis Research Laboratory, University Hospital, University of Bern, Bern, Switzerland

²Department of Internal Medicine, Spital Netz Bern Hospitals, Bern, Switzerland

› Institutsangaben

Abstract

Confirmation of suspected congenital factor XIII (FXIII) deficiency still represents a diagnostic challenge in the field of rare bleeding disorders. Because of the lack of awareness and difficulties associated with timing of blood sampling, FXIII laboratory assays, and interpretation of laboratory results, diagnoses of FXIII deficiency are still missed all over the world with potentially fatal consequences from severe bleeding complications. Better knowledge of FXIII biochemical properties and function and understanding of the principles and limitations of FXIII laboratory assays can prevent missed diagnoses, and patients will benefit from better care. This review gives a detailed overview and update about congenital FXIII deficiency, its epidemiology, and molecular genetics. It highlights the importance of newer specific FXIII assays and their principles to avoid any missed diagnosis of FXIII deficiency. This review also gives an update on the therapeutic options for patients suffering from this rare but life-threatening disease.

Keywords

factor XIII - rare bleeding disorders - congenital FXIII deficiency - transglutaminase

Volltext

Referenzen

References
1 Perez DL, Diamond EL, Castro CM , et al. Factor XIII deficiency related recurrent spontaneous intracerebral hemorrhage: a case and literature review. Clin Neurol Neurosurg 2011; 113 (2) 142-145
2 Karimi M, Bereczky Z, Cohan N, Muszbek L. Factor XIII deficiency. Semin Thromb Hemost 2009; 35 (4) 426-438
3 Muszbek L, Bereczky Z, Bagoly Z, Komáromi I, Katona E. Factor XIII: a coagulation factor with multiple plasmatic and cellular functions. Physiol Rev 2011; 91 (3) 931-972
4 Lord ST. Molecular mechanisms affecting fibrin structure and stability. Arterioscler Thromb Vasc Biol 2011; 31 (3) 494-499
5 Fraser SR, Booth NA, Mutch NJ. The antifibrinolytic function of factor XIII is exclusively expressed through α₂-antiplasmin cross-linking. Blood 2011; 117 (23) 6371-6374
6 Inbal A, Lubetsky A, Krapp T , et al. Impaired wound healing in factor XIII deficient mice. Thromb Haemost 2005; 94 (2) 432-437
7 Dardik R, Loscalzo J, Inbal A. Factor XIII (FXIII) and angiogenesis. J Thromb Haemost 2006; 4 (1) 19-25
8 Ichinose A, Asahina T, Kobayashi T. Congenital blood coagulation factor XIII deficiency and perinatal management. Curr Drug Targets 2005; 6 (5) 541-549
9 Schroeder V, Kohler HP. New developments in the area of factor XIII. J Thromb Haemost 2013; 11 (2) 234-244
10 Anwar R, Minford A, Gallivan L, Trinh CH, Markham AF. Delayed umbilical bleeding—a presenting feature for factor XIII deficiency: clinical features, genetics, and management. Pediatrics 2002; 109 (2) E32
11 Duckert F, Jung E, Shmerling DH. A hitherto undescribed congenital haemorrhagic diathesis probably due to fibrin stabilizing factor deficiency. Thromb Diath Haemorrh 1960; 5: 179-186
12 Laki K, Lóránd L. On the solubility of fibrin clots. Science 1948; 108 (2802) 280
13 Schroeder V, Meili E, Cung T, Schmutz P, Kohler HP. Characterisation of six novel A-subunit mutations leading to congenital factor XIII deficiency and molecular analysis of the first diagnosed patient with this rare bleeding disorder. Thromb Haemost 2006; 95 (1) 77-84
14 Anwar R, Miloszewski KJ. Factor XIII deficiency. Br J Haematol 1999; 107 (3) 468-484
15 Board PG, Losowsky MS, Miloszewski KJ. Factor XIII: inherited and acquired deficiency. Blood Rev 1993; 7 (4) 229-242
16 Muszbek L, Bagoly Z, Cairo A, Peyvandi F. Novel aspects of factor XIII deficiency. Curr Opin Hematol 2011; 18 (5) 366-372
17 Peyvandi F, Duga S, Akhavan S, Mannucci PM. Rare coagulation deficiencies. Haemophilia 2002; 8 (3) 308-321
18 Biswas A, Ivaskevicius V, Seitz R, Thomas A, Oldenburg J. An update of the mutation profile of Factor 13 A and B genes. Blood Rev 2011; 25 (5) 193-204
19 Hashiguchi T, Saito M, Morishita E, Matsuda T, Ichinose A. Two genetic defects in a patient with complete deficiency of the b-subunit for coagulation factor XIII. Blood 1993; 82 (1) 145-150
20 Koseki S, Souri M, Koga S , et al. Truncated mutant B subunit for factor XIII causes its deficiency due to impaired intracellular transportation. Blood 2001; 97 (9) 2667-2672
21 Izumi T, Hashiguchi T, Castaman G , et al. Type I factor XIII deficiency is caused by a genetic defect of its b subunit: insertion of triplet AAC in exon III leads to premature termination in the second Sushi domain. Blood 1996; 87 (7) 2769-2774
22 Souri M, Izumi T, Higashi Y, Girolami A, Ichinose A. A founder effect is proposed for factor XIII B subunit deficiency caused by the insertion of triplet AAC in exon III encoding the second Sushi domain. Thromb Haemost 1998; 80 (2) 211-213
23 Ivaskevicius V, Biswas A, Loreth R , et al. Mutations affecting disulphide bonds contribute to a fairly common prevalence of F13B gene defects: results of a genetic study in 14 families with factor XIII B deficiency. Haemophilia 2010; 16 (4) 675-682
24 Ivaskevicius V, Seitz R, Kohler HP , et al; Study Group. International registry on factor XIII deficiency: a basis formed mostly on European data. Thromb Haemost 2007; 97 (6) 914-921
25 Kohler HP, Ichinose A, Seitz R, Ariens RAS, Muszbek L. Factor XIII and Fibrinogen SSC Subcommittee of the ISTH. Diagnosis and classification of factor XIII deficiencies. J Thromb Haemost 2011; 9 (7) 1404-1406
26 Ivaskevicius V, Biswas A, Thomas A , et al. Identification of two novel missense mutations in F13A gene affecting thrombin cleavage site (Arg37) of factor XIII A-subunit. Hamostaseologie 2012; 32 (1) A2-A107 [abstract ED20–5, A22]
27 Egbring R, Seitz R, Gürten GV, Köther M, Barthels M, Fuchs G. Bleeding complications in heterozygotes with congenital factor XIII deficiency. In: Mosesson MW, ed. Fibrinogen—Biochemistry, Biological Functions, Gene Regulation and Expression. Amsterdam: Elsevier; 1988: 341-346
28 Seitz R, Duckert F, Lopaciuk S, Muszbek L, Rodeghiero F, Seligsohn U. Study Group. ETRO Working Party on Factor XIII questionnaire on congenital factor XIII deficiency in Europe: status and perspectives. Semin Thromb Hemost 1996; 22 (5) 415-418
29 Mahmoodi M, Peyvandi F, Afrasiabi A, Ghaffarpasand F, Karimi M. Bleeding symptoms in heterozygous carriers of inherited coagulation disorders in southern Iran. Blood Coagul Fibrinolysis 2011; 22 (5) 396-401
30 Bolton-Maggs PH, Favaloro EJ, Hillarp A, Jennings I, Kohler HP. Difficulties and pitfalls in the laboratory diagnosis of bleeding disorders. Haemophilia 2012; 18 (Suppl. 04) 66-72
31 Kárpáti L, Penke B, Katona E, Balogh I, Vámosi G, Muszbek L. A modified, optimized kinetic photometric assay for the determination of blood coagulation factor XIII activity in plasma. Clin Chem 2000; 46 (12) 1946-1955
32 Wilmer M, Rudin K, Kolde H , et al. Evaluation of a sensitive colorimetric FXIII incorporation assay. Effects of FXIII Val34Leu, plasma fibrinogen concentration and congenital FXIII deficiency. Thromb Res 2001; 102 (1) 81-91
33 Ajzner E, Muszbek L. Kinetic spectrophotometric factor XIII activity assays: the subtraction of plasma blank is not omissible [corrected]. J Thromb Haemost 2004; 2 (11) 2075-2077
34 Ichinose A. Hemorrhagic acquired factor XIII (13) deficiency and acquired hemorrhaphilia 13 revisited. Semin Thromb Hemost 2011; 37 (4) 382-388
35 Gerlach R, Tölle F, Raabe A, Zimmermann M, Siegemund A, Seifert V. Increased risk for postoperative hemorrhage after intracranial surgery in patients with decreased factor XIII activity: implications of a prospective study. Stroke 2002; 33 (6) 1618-1623
36 Kucher N, Schroeder V, Kohler HP. Role of blood coagulation factor XIII in patients with acute pulmonary embolism. Correlation of factor XIII antigen levels with pulmonary occlusion rate, fibrinogen, D-dimer, and clot firmness. Thromb Haemost 2003; 90 (3) 434-438
37 Kohler HP, Ariëns RAS, Catto AJ , et al. Factor XIII A-subunit concentration predicts outcome in stroke subjects and vascular outcome in healthy, middle-aged men. Br J Haematol 2002; 118 (3) 825-832
38 Seitz R, Leugner F, Katschinski M , et al. Ulcerative colitis and Crohn's disease: factor XIII, inflammation and haemostasis. Digestion 1994; 55 (6) 361-367
39 Zeerleder S, Schroeder V, Lämmle B, Wuillemin WA, Hack CE, Kohler HP. Factor XIII in severe sepsis and septic shock. Thromb Res 2007; 119 (3) 311-318
40 Matsuoka M, Majima T, Onodera T , et al. Hemorrhagic-acquired factor XIII deficiency associated with tocilizumab for treatment of rheumatoid arthritis. Int J Hematol 2012; 96 (6) 781-785
41 Lorand L, Maldonado N, Fradera J, Atencio AC, Robertson B, Urayama T. Haemorrhagic syndrome of autoimmune origin with a specific inhibitor against fibrin stabilizing factor (factor XIII). Br J Haematol 1972; 23 (1) 17-27
42 Lorand L, Velasco PT, Rinne JR, Amare M, Miller LK, Zucker ML. Autoimmune antibody (IgG Kansas) against the fibrin stabilizing factor (factor XIII) system. Proc Natl Acad Sci U S A 1988; 85 (1) 232-236
43 Fukue H, Anderson K, McPhedran P, Clyne L, McDonagh J. A unique factor XIII inhibitor to a fibrin-binding site on factor XIIIA. Blood 1992; 79 (1) 65-74
44 Hayashi T, Kadohira Y, Morishita E, Asakura H, Souri M, Ichinose A. A case of acquired FXIII deficiency with severe bleeding symptoms. Haemophilia 2012; 18 (4) 618-620
45 Sugiyama H, Uesugi H, Suzuki S, Tanaka K, Souri M, Ichinose A. Aggressive fatal case of autoimmune hemorrhaphilia resulting from anti-Factor XIII antibodies. Blood Coagul Fibrinolysis 2013; 24 (1) 85-89
46 Ajzner E, Schlammadinger A, Kerényi A , et al. Severe bleeding complications caused by an autoantibody against the B subunit of plasma factor XIII: a novel form of acquired factor XIII deficiency. Blood 2009; 113 (3) 723-725
47 Boehlen F, Casini A, Chizzolini C , et al. Acquired factor XIII deficiency: a therapeutic challenge. Thromb Haemost 2013; 109 (3) 479-487
48 Nugent DJ. Prophylaxis in rare coagulation disorders—factor XIII deficiency. Thromb Res 2006; 118 (Suppl. 01) S23-S28
49 Inbal A, Oldenburg J, Carcao M, Rosholm A, Tehranchi R, Nugent D. Recombinant factor XIII: a safe and novel treatment for congenital factor XIII deficiency. Blood 2012; 119 (22) 5111-5117
50 Kohler HP. Novel treatment for congenital FXIII deficiency. Blood 2012; 119 (22) 5060-5061
51 Coggan M, Baker R, Miloszewski K, Woodfield G, Board P. Mutations causing coagulation factor XIII subunit A deficiency: characterization of the mutant proteins after expression in yeast. Blood 1995; 85 (9) 2455-2460
52 Peyvandi F, Tagliabue L, Menegatti M , et al. Phenotype-genotype characterization of 10 families with severe a subunit factor XIII deficiency. Hum Mutat 2004; 23 (1) 98
53 Halverstadt A, Walsh S, Roth SM, Ferrell RE, Hagberg JM. Identification of a novel mutation combination in factor XIII deficiency: genetic update to the first reported case in the United States. Int J Hematol 2006; 83 (2) 144-146
54 Ivaskevicius V, Biswas A, Bevans C , et al. Identification of eight novel coagulation factor XIII subunit A mutations: implied consequences for structure and function. Haematologica 2010; 95 (6) 956-962
55 Castaman G, Giacomelli SH, Ivaskevicius V , et al. Molecular characterization of five Italian families with inherited severe factor XIII deficiency. Haemophilia 2008; 14 (1) 96-102
56 Trinh CH, Sh Elsayed W, Eshghi P , et al. Molecular analysis of sixteen unrelated factor XIIIA deficient families from south-east of Iran. Br J Haematol 2008; 140 (5) 581-584
57 Vysokovsky A, Saxena R, Landau M , et al. Seven novel mutations in the factor XIII A-subunit gene causing hereditary factor XIII deficiency in 10 unrelated families. J Thromb Haemost 2004; 2 (10) 1790-1797
58 Vysokovsky A, Rosenberg N, Dardik R, Seligsohn U, Inbal A. Effect of four missense mutations in the factor XIII A-subunit gene on protein stability: studies with recombinant proteins. Blood Coagul Fibrinolysis 2006; 17 (2) 125-130
59 Birben E, Oner C, Oner R, Altay C, Gürgey A. Identification of an inframe deletion and a missense mutation in the factor XIIIA gene in two Turkish patients. Eur J Haematol 2003; 71 (1) 39-43
60 Mikkola H, Syrjälä M, Rasi V , et al. Deficiency in the A-subunit of coagulation factor XIII: two novel point mutations demonstrate different effects on transcript levels. Blood 1994; 84 (2) 517-525
61 Mikkola H, Yee VC, Syrjälä M , et al. Four novel mutations in deficiency of coagulation factor XIII: consequences to expression and structure of the A-subunit. Blood 1996; 87 (1) 141-151
62 Kangsadalampai S, Chelvanayagam G, Baker R, Tiedemann K, Kuperan P, Board PG. Identification and characterization of two missense mutations causing factor XIIIA deficiency. Br J Haematol 1999; 104 (1) 37-43
63 Ichinose A, Tsukamoto H, Izumi T , et al. Arg260-Cys mutation in severe factor XIII deficiency: conformational change of the A subunit is predicted by molecular modelling and mechanics. Br J Haematol 1998; 101 (2) 264-272
64 Onland W, Böing AN, Meijer AB , et al. Congenital deficiency of factor XIII caused by two missense mutations in a Dutch family. Haemophilia 2005; 11 (5) 539-547
65 Jayandharan GR, Viswabandya A, Baidya S , et al. Mutations in coagulation factor XIII A gene in eight unrelated Indians. Five novel mutations identified by a novel PCR-CSGE approach. Thromb Haemost 2006; 95 (3) 551-556
66 Souri M, Ichinose A. Impaired protein folding, dimer formation, and heterotetramer assembly cause intra- and extracellular instability of a Y283C mutant of the A subunit for coagulation factor XIII. Biochemistry 2001; 40 (45) 13413-13420
67 Souri M, Yee VC, Kasai K , et al. Novel Y283C mutation of the A subunit for coagulation factor XIII: molecular modelling predicts its impaired protein folding and dimer formation. Br J Haematol 2001; 113 (3) 652-654
68 Anwar R, Gallivan L, Miloszewski KJ, Markham AF. Factor XIII deficiency causing mutation, Ser295Arg, in exon 7 of the factor XIIIA gene. Thromb Haemost 2000; 84 (4) 591-594
69 Gómez García EB, Poort SR, Stibbe J , et al. Two novel and one recurrent missense mutation in the factor XIII A gene in two Dutch patients with factor XIII deficiency. Br J Haematol 2001; 112 (2) 513-518
70 Mikkola H, Muszbek L, Haramura G, Hämäläinen E, Jalanko A, Palotie A. Molecular mechanisms of mutations in factor XIII A-subunit deficiency: in vitro expression in COS-cells demonstrates intracellular degradation of the mutant proteins. Thromb Haemost 1997; 77 (6) 1068-1072
71 Anwar R, Gallivan L, Trinh C, Hill F, Markham A. Identification of a new Leu354Pro mutation responsible for factor XIII deficiency. Eur J Haematol 2001; 66 (2) 133-136
72 Ivaskevicius V, Windyga J, Baran B , et al. Phenotype-genotype correlation in eight Polish patients with inherited Factor XIII deficiency: identification of three novel mutations. Haemophilia 2007; 13 (5) 649-657
73 Izumi T, Nagaoka U, Saito T, Takamatsu J, Saito H, Ichinose A. Novel deletion and insertion mutations cause splicing defects, leading to severe reduction in mRNA levels of the A subunit in severe factor XIII deficiency. Thromb Haemost 1998; 79 (3) 479-485
74 Anwar R, Miloszewski KJ, Markham AF. Identification of a large deletion, spanning exons 4 to 11 of the human factor XIIIA gene, in a factor XIII-deficient family. Blood 1998; 91 (1) 149-153
75 Niiya T, Osawa H, Bando S , et al. A complete deficiency of coagulation factor XIII A-subunit due to a novel compound heterozygote of Ser 413 Leu missense and an nt 389 (ins G) frameshift mutation. Br J Haematol 1999; 107 (4) 772-775
76 Duan B, Wang X, Chu H , et al. Deficiency of factor XIII gene in Chinese: 3 novel mutations. Int J Hematol 2003; 78 (3) 251-255
77 Aslam S, Yee VC, Narayanan S, Duraisamy G, Standen GR. Structural analysis of a missense mutation (Val414Phe) in the catalytic core domain of the factor XIII(A) subunit. Br J Haematol 1997; 98 (2) 346-352
78 Kangsadalampai S, Yenchitsomanus P, Chelvanayagam G, Sawasdee N, Laosombat V, Board P. Identification of a new mutation (Gly420Ser), distal to the active site, that leads to factor XIII deficiency. Eur J Haematol 2000; 65 (4) 279-284
79 Anwar R, Gallivan L, Miloszewski KJ, Markham AF. Splicing and missense mutations in the human FXIIIA gene causing FXIII deficiency: effects of these mutations on FXIIIA RNA processing and protein structure. Br J Haematol 1998; 103 (2) 425-428
80 Takahashi N, Tsukamoto H, Umeyama H, Castaman G, Rodeghiero F, Ichinose A. Molecular mechanisms of type II factor XIII deficiency: novel Gly562-Arg mutation and C-terminal truncation of the A subunit cause factor XIII deficiency as characterized in a mammalian expression system. Blood 1998; 91 (8) 2830-2838
81 Inbal A, Yee VC, Kornbrot N, Zivelin A, Brenner B, Seligsohn U. Factor XIII deficiency due to a Leu660Pro mutation in the factor XIII subunit-a gene in three unrelated Palestinian Arab families. Thromb Haemost 1997; 77 (6) 1062-1067
82 Aslam S, Poon MC, Yee VC, Bowen DJ, Standen GR. Factor XIIIA Calgary: a candidate missense mutation (Leu667Pro) in the beta barrel 2 domain of the factor XIIIA subunit. Br J Haematol 1995; 91 (2) 452-457
83 Wu SY, Wang ZY, Dong NZ, Zhang W, Bai X, Ruan CG. [A novel genetic defect in a Chinese family with inherited coagulation factor XIII deficiency]. Zhonghua Xue Ye Xue Za Zhi 2006; 27 (3) 145-149
84 Anwar R, Langlois S. The Arg703Trp missense mutation in F13A1 is a de novo event. Br J Haematol 2009; 146 (1) 118-120
85 Standen GR, Bowen DJ. Factor XIII ABristol 1: detection of a nonsense mutation (Arg171—>stop codon) in factor XIII A subunit deficiency. Br J Haematol 1993; 85 (4) 769-772
86 Zheng WD, Liu YH, He QY, Chen ZH, Fan XB, Liu HF. [Identification of Arg77Cys and Arg174stop double heterozygous mutation in a Chinese family with inherited FXIII deficiency]. Zhonghua Xue Ye Xue Za Zhi 2009; 30 (3) 158-161
87 Anwar R, Gallivan L, Richards M, Khair K, Wright M, Minford A. Factor XIII deficiency: new nonsense and deletion mutations in the human factor XIIIA gene. Haematologica 2005; 90 (12) 1718-1720
88 Kangsadalampai S, Farges-Berth A, Caglayan SH, Board PG. New mutations causing the premature termination of translation in the A subunit gene of coagulation factor XIII. Thromb Haemost 1996; 76 (2) 139-142
89 Anwar R, Stewart AD, Miloszewski KJ, Losowsky MS, Markham AF. Molecular basis of inherited factor XIII deficiency: identification of multiple mutations provides insights into protein function. Br J Haematol 1995; 91 (3) 728-735
90 Kamura T, Okamura T, Murakawa M , et al. Deficiency of coagulation factor XIII A subunit caused by the dinucleotide deletion at the 5′ end of exon III. J Clin Invest 1992; 90 (2) 315-319
91 Aslam S, Bowen DJ, Mandalaki T, Gialeraki R, Standen GR. Factor XIII(A) subunit deficiency due to a homozygous 13-base pair deletion in exon 3 of the A subunit gene. Am J Hematol 1996; 53 (2) 77-80
92 Otaki M, Inaba H, Shinozawa K, Fujita S, Amano K, Fukutake K. [Characterization of a large deletion that leads to congenital factor XIII deficiency]. Rinsho Byori 2008; 56 (3) 187-194
93 Trigui N, Frère C, D'Ercole C , et al. Molecular characterization of a novel mutation in the factor XIII A subunit gene associated with a severe defect and an adulthood diagnosis. Haemophilia 2007; 13 (2) 221-222
94 Kangsadalampai S, Chelvanayagam G, Baker RT , et al. A novel Asn344 deletion in the core domain of coagulation factor XIII A subunit: its effects on protein structure and function. Blood 1998; 92 (2) 481-487
95 Aslam S, Standen GR, Bruce LJ, Gialeraki R, Mandalaki T. A novel insertion mutation (1286insC) in exon 9 of the factor XIII-A subunit gene. Blood Coagul Fibrinolysis 1998; 9 (5) 441-443
96 Jiao WY, Wu JS, Ding QL , et al. [Identification of a novel mutation of F (13) A gene in a pedigree with factor XIII deficiency]. Zhonghua Xue Ye Xue Za Zhi 2007; 28 (9) 598-601
97 Birben E, Oner R, Oner C, Gümrük F, Altay C, Gürgey A. Mutations in coagulation factor XIII A gene in three Turkish patients: two novel mutations and a known insertion. Br J Haematol 2002; 118 (1) 278-281
98 Mikkola H, Muszbek L, Laiho E , et al. Molecular mechanism of a mild phenotype in coagulation factor XIII (FXIII) deficiency: a splicing mutation permitting partial correct splicing of FXIII A-subunit mRNA. Blood 1997; 89 (4) 1279-1287
99 Vreken P, Niessen RW, Peters M, Schaap MC, Zuithoff-Rijntjes JG, Sturk A. A point mutation in an invariant splice acceptor site results in a decreased mRNA level in a patient with severe coagulation factor XIII subunit A deficiency. Thromb Haemost 1995; 74 (2) 584-589
100 Maak B, Kochhan L, Heuchel P, Jenderny J. FXIII deficiency due to base exchange Thr 449 (ACT) —> Ile (ATT) in exon 11 of the factor 13A gene. A cause of bleeding?. Hamostaseologie 2010; 30 (3) 162-164
101 Khalife H, Muwakkit S, Al-Moussawi H , et al. Spontaneous splenic rupture in a patient with factor XIII deficiency and a novel mutation. Pediatr Blood Cancer 2008; 50 (1) 113-114
102 Morange P, Trigui N, Frère C , et al. Molecular characterization of a novel mutation in the factor XIII a subunit gene associated with a severe defect: importance of prophylactic substitution. Blood Coagul Fibrinolysis 2009; 20 (7) 605-606
103 Souri M, Yee VC, Fujii N, Ichinose A. Molecular modeling predicts structural changes in the A subunit of factor XIII caused by two novel mutations identified in a neonate with severe congenital factor XIII deficiency. Thromb Res 2012; 130 (3) 506-510
104 Castaman G, Giacomelli SH, Schroeder V , et al. Further evidence of heterogeneity of gene defects in Italian families with factor XIII deficiency. Haemophilia 2012; 18 (1) e6-e8
105 Shanbhag S, Shetty S, Ghosh K. Mutations in coagulation factor XIII subunit A in severe factor XIII deficiency patients: five novel mutations detected. Haemophilia 2011; 17 (5) e843-e845
106 Ichinose A, Davie EW. Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor. Proc Natl Acad Sci U S A 1988; 85 (16) 5829-5833